Tricyclic anilide spirolactam CGRP receptor antagonists

Details for Australian Patent Application No. 2005285270 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Zartman, C Blair; Theberge, Cory R.; Zhang, Xufang; Gallicchio, Steven N.; Vacca, Joseph P.; Stump, Craig A.; Bell, Ian M.

Agent Spruson & Ferguson

Pub. Number AU-B-2005285270

PCT Pub. Number WO2006/031491

Priority 60/608,294 09.09.04 US

Filing date 6 September 2005

Wipo publication date 23 March 2006

Acceptance publication date 21 April 2011

International Classifications

C07D 471/02 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/505 (2006.01) - Pyrimidines

Event Publications

15 March 2007 PCT application entered the National Phase

  PCT publication WO2006/031491 Priority application(s): WO2006/031491

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

21 April 2011 Application Accepted

  Published as AU-B-2005285270

18 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005285271-Single solvent polymer extraction methods

2005285267-Seamless channel change in a wireless local area network